Maosheng Hung, Ph.D.
Affiliations: | 2008 | Curriculum and Teaching | University of Kansas, Lawrence, KS, United States |
Area:
Language and Literature EducationGoogle:
"Maosheng Hung"Parents
Sign in to add mentor| Paul Markham | grad student | 2008 | University of Kansas | |
| (The relationship between onset age and instruction time at school and Taiwanese EFL learners' perception of English vowels.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang YL, Lee CC, Shen YC, et al. (2021) Evading immune surveillance via tyrosine phosphorylation of nuclear PCNA. Cell Reports. 36: 109537 |
| Lee HH, Wang YN, Yang WH, et al. (2021) Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation. Nature Communications. 12: 2788 |
| Cho J, Min HY, Lee HJ, et al. (2021) RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse. The Journal of Clinical Investigation. 131 |
| Chen M, Xia W, Dong Q, et al. (2020) Abstract 5682: Synergism of PARP inhibitor and MET inhibitor in multiple cancer types with intrinsic and acquired PARP inhibitor resistances Cancer Research. 80: 5682-5682 |
| Pataer A, Ozpolat B, Shao R, et al. (2019) Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells. Oncogene |
| Wang P, Gong Y, Guo T, et al. (2019) Activation of Aurora A kinase increases YAP stability via blockage of autophagy. Cell Death & Disease. 10: 432 |
| Liu YL, Chou CK, Kim M, et al. (2019) Assessing metastatic potential of breast cancer cells based on EGFR dynamics. Scientific Reports. 9: 3395 |
| Kim J, Piao HL, Kim BJ, et al. (2018) Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nature Genetics |
| Xing Z, Zhang Y, Liang K, et al. (2018) Expression of long non-coding RNA YIYA promotes glycolysis in breast cancer. Cancer Research |
| Zhang P, Xiao Z, Wang S, et al. (2018) ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer. Cell Reports. 23: 823-837 |